Unsurprisingly, CRC patients with high MUC5 expression showed poor cell differentiation, a high lymph node metastasis rate and late stage CRC (Wang et al., 2017), which suggests that MUC5AC is a promoter of tumors. Here, MUC5B is linked to colorectal carcinoma.